Sleep Disorders Trial, Recruiting NCT06916936 Sponsor: Florida State University Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT06916936
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children who are currently enrolled in elementary or middle school (grades 1 through 8)
  • Children who are between 6 and 13 years old
  • Children who are able to speak and read in English

Who may not be able to join:

  • Children who have taken antibiotics in the past 3 months
  • Children who have taken prebiotics, probiotics, or postbiotics (supplements that affect gut bacteria) in the past 3 months
  • Children who have a food allergy to any of the foods used in the study, including any allergy to nuts or peanuts
  • Children who have an allergy to chocolate or wheat
  • Children who regularly eat nuts or peanuts more than 2 servings per week
  • Children who have a digestive system condition such as ulcerative colitis, Crohn's disease, irritable bowel syndrome, or acid reflux, among others (confirm with trial site for the full list)
  • Children who have a neurological condition such as multiple sclerosis, meningitis, or a recent stroke
  • Children who have an uncontrolled hormone or gland condition, such as uncontrolled thyroid problems, growth hormone disorders, adrenal gland disorders, or poorly controlled diabetes
  • Children who are known to be pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ravinder Nagpal, Ph.D., Florida State University

Phone: 850-644-1828

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Florida State University
Registry
ClinicalTrials.gov
Start date
9 February 2025
Est. completion
1 May 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Gut Microbiome Diversity; Change in Oral Microbiome Diversity; Change in Fecal Metabolome; Change in Serum Metabolome

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov